Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 4Melanoma 4Skin Neoplasms 3Neoplasm Metastasis 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Otorhinolaryngologic Neoplasms 1Lip Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Carcinoma 1

Interventions

Cisplatin 8Radiotherapy 4Pemetrexed 4Cetuximab 4Gemcitabine 3Gefitinib 2Fluorouracil 2Drug Therapy 2Docetaxel 2Carboplatin 2pembrolizumab 1X-Rays 1Vitamin B 12 1Tirapazamine 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Paclitaxel 1Nivolumab 1Nimorazole 1Narrow Band Imaging 1Metformin 1MLN 8237 1LY2940680 1Ipilimumab 1Hydroxyurea 1Gabapentin 1Folic Acid 1Fibroblast Growth Factor 7 1Chemical Fractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Laryngeal Diseases × Allovectin-7 × Clear all
NCT00050388 2008-06-24

Phase II Trial of Allovectin-7® for Head and Neck Cancer

Vical

Phase 3 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases, Lip Neoplasms, Neoplasms, Otorhinolaryngologic Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡